Feature | April 08, 2011

FDA Approves Aneurysm Treatment System

April 8, 2011 – The U.S. Food and Drug Administration (FDA) has approved an aneurysm treatment system as a Humanitarian Use Device (HDE). NeuroVasx’s cPAX Aneurysm Treatment System can be used to treat large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat.

The HDE allows for the treatment of up to 4,000 patients per year in the United States.

"The large, giant and wide-neck cerebral aneurysm population continues to remain the most challenging to treat,” said Christopher Dowd, M.D., clinical professor of neuro-interventional radiology at the University of California at San Francisco and medical director for NeuroVasx. “cPAX will offer physicians an alternative solution that we believe can make a significant impact in treatment and outcome for these patients."

"The longer term stability we have seen in the clinical studies using cPAX in larger aneurysms gives me great confidence in the positive impact this product will have on the care of our patients,” said Ricardo Hanel, M.D., Ph.D., associate professor of neurosurgery at the Mayo Clinic in Jacksonville, Fla., and co-principal investigator in the cPAX Clinical Trial.

A cerebral aneurysm is an abnormal bulge or sac in the wall of an artery in the brain which can be caused by a number of factors including congenital defects, high blood pressure, atherosclerosis, cancer, drug use or head trauma. If a cerebral aneurysm ruptures, it can lead to a hemorrhagic stroke, or bleeding on the brain.

According to the National Institutes of Health, approximately 40 percent of these patients do not survive the first 24 hours. The worldwide incidence of cerebral aneurysms is estimated to be 320,000 annually, approximately 200,000 of which may be treatable with intracranial surgery using minimally invasive techniques.

cPAX is a polymeric strand delivered into the aneurysm using a technique similar to platinum coil technologies. Because of its soft polymeric material, the device is designed to achieve more complete filling of the aneurysm with the probable benefit of greater long-term stability. A significant feature is that it offers the physician the ability to detach the device at any point. The polymeric material also allows for non-invasive CT and MRI scans with little or no artifact for more accurate patient follow-up assessment.

For more information: www.neurovasx.com

Related Content

Louisiana Medical Center Installs First U.S. Toshiba Medical Infinix-i Sky +
News | Angiography| April 18, 2017
April 18, 2017 — Patients at Terrebonne General Medical Center (TGMC) in Houma, La., now have access to safe, high-qu
Society of Interventional Radiology, SIR, 2017 Gold Medal winners
News | Interventional Radiology| March 14, 2017
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to three individuals...
ACR, American College of Radiology, SIR, Society of Interventional Radiology, interventional radiology, IR Registry
News | Interventional Radiology| March 01, 2017
Through participation in the new Interventional Radiology (IR) Registry, interventional radiologists can take steps to...
Technology | Pulmonary Embolism| March 01, 2017
March 1, 2017 — BTG plc announced U.S.
Neiman Institute study, national trends, enteral access procedures, JVIR, Journal of Vascular and Interventional Radiology
News | Interventional Radiology| January 11, 2017
According to a recent study by the Harvey L. Neiman Health Policy Institute, the last two decades have seen a...
Siemens artis pheno angiography system
Technology | Angiography| January 04, 2017
January 4, 2015 — At RSNA 2016, Siemens Healthineers unveiled its 510(k)-pending robot-supported Artis pheno angiogra
Sponsored Content | Videos | Angiography| December 07, 2016
Shimadzu's latest generation interventional lab angiography imaging system, the Trinias, enables advanced imaging cap
Siemens Healthineers, PURE Platform, angiography, EVAR, CTO, RSNA 2016
News | Angiography| December 07, 2016
December 7, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
Infinix-i Sky +, RSNA 2016, Toshiba, angiography systems

Toshiba Medical’s Infinix-i product line, including the Infinix-i Sky +, delivers patient access, image quality and safety features for virtually any image-guided procedure, including those in hybrid OR settings.

News | Angiography| November 21, 2016
November 21, 2016 – Healthcare providers seeking versatile imaging technology for their angiography needs can find a
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab| October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
Overlay Init